Feasibility of in-office endoscopic sinus surgery with balloon sinus dilation

Abstract

Background: Balloon sinus dilation (BSD)

Long-term follow-up after ESS and balloon sinuplasty: Comparison of symptom reduction and patient satisfaction

“…At 52 weeks, 95% indicated a willingness to have the procedure again, and 100% (21/21) would recommend it to family or close friends [17]. This is in line with our observations of high satisfactions with both ESS and balloon techniques.…”

Safety and outcomes following hybrid balloon and balloon‐only procedures using a multifunction, multisinus balloon dilation tool

“…Revision rates were within the range of prior published results from endoscopic sinus surgery (ESS) case series and single‐center retrospective analyses . Results from several subsequent studies demonstrated balloon dilation can be safely and comfortably performed in a clinic setting under local anesthesia with a high rate of intraoperative treatment success and similar trends in postoperative outcomes …”

“…The study results from this trial would have been strengthened by including additional objective performance criteria to assess treatment efficacy. Since completion of this study, balloon‐only sinus dilation cases have become more prevalent and reports indicate that such procedures are being performed successfully in the clinic . Randomized, comparative trials are necessary to further evaluate outcomes in a specific population of surgical candidates who undergo treatment with either standalone balloon dilation or ESS.…”

Office‐based balloon sinus dilation: a prospective, multicenter study of 203 patients

“…The patient‐reported outcomes are limited by lack of a baseline questionnaire and use of a nonvalidated survey. A recent report including 37 patients with CRS demonstrated feasibility of in‐office BSD for all sinuses, technical success, procedure tolerability, and clinically and statistically improvement in patient symptoms . In this study, we enrolled over 200 patients with disease in all of the peripheral sinuses, and used a validated QOL instrument and an objective radiographic measure of disease burden change.…”